Anti-Venom Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Anti-Venom Market Research and Forecast
Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Anti-Venom Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2023-2028," the global anti-venom market
  size reached US 1,096.1 Million in 2022.
• Anti-venom, also known as antivenin, or venom
  antiserum, are antibodies that are used to stop
  snake venom from causing severe allergic
  reactions, blood clotting, muscle injury, or
  nervous system problems. It also treats scorpion,
  spider, jellyfish, and stone fish bites.
• It is obtained from various animals using
  different methods, such as milking or dissection.
  As anti-venoms can prevent or reverse the
  envenoming effects and help minimize mortality
  and morbidity, they are widely used to treat
  patients depending on their history, examination,
  geographic, clinical, and pathologic factors.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/anti-venom-market/reque
  stsample

4
Report Description

• Global Anti-Venom Market Trends
• The market is primarily driven by the rising
  incidences of snakebites, especially in rural
  areas. Another major growth-inducing factor is
  open-plan housing and the practice of sleeping on
  the floor, that can expose people to highly
  venomous snakes. This can cause serious health
  problems, including kidney failure, severe
  paralysis that prevents breathing, bleeding
  disorders that can lead to fatal hemorrhage, and
  severe local tissue destruction that can cause
  permanent disability.
• Besides this, the introduction of snake venom
  detection kits for in vitro detection and
  immunological identification of snake venom in
  samples from bite sites, urine, plasma, blood, or
  other tissues and body fluids is propelling the
  market growth. Moreover, the rising awareness
  among the masses regarding snakebite treatment
  and the development of advanced anti-venoms are
  also creating a positive market outlook across
  the globe.
• Looking forward, IMARC Group expects the market
  value to reach US 1,644.9 Million by 2028,
  exhibiting a CAGR of 6.7 during 2023-2028.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/anti-venom-market

5
Report Segmentation

• Species Insights
• Snake
• Scorpion
• Spider
• Others
•  
• Anti-venom Type Insights
• Polyvalent Anti-venom
• Monovalent Anti-venom
• Mode of Action Insights
• Cytotoxic
• Neurotoxic
• Haemotoxic
• Cardiotoxic

6
Report Segmentation

• Myotoxic
• Others
• End User Insights
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Regional Insights
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Bharat Serums and Vaccines Limited (BSV)
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• CSL Limited
• Haffkine Bio-Pharmaceutical Corporation Limited
• Incepta Pharmaceuticals Limited
• Merck Co. Inc.
• Merck KGaA
• MicroPharm Limited
• Pfizer Inc.
• Rare Disease Therapeutics Inc.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Anti-Venom Market   
  5.1    Market Overview    5.2    Market
  Performance    5.3    Impact of COVID-19  5.4
     Market Forecast
• 6     Market Breakup by Species
•   6.1    Snake    6.1.1 Market Trends     
   6.1.2 Market Forecast    6.2 Scorpion   
  6.2.1  Market Trends       6.2.2 Market
  Forecast    6.3 Spider    6.3.1 Market
  Trends       6.3.2 Market Forecast       

11
Table of Contents

• 6.4 Others
• 6.4.1 Market Trends
• 6.4.2 Market Forecast
• 7  Market Breakup by Anti-venom Type
• 7.1 Polyvalent Anti-venom
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Monovalent Anti-venom
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 8  Market Breakup by Mode of Action
• 8.1 Cytotoxic
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Neurotoxic
• 8.2.1 Market Trends
• 8.2.2 Market Forecast
• 8.3 Haemotoxic
• 8.3.1 Market Trends

12
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

13
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com